Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Medisure Laboratories Pakistan Pvt Ltd

Pharmaceutical manufacturer · Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Regulatory & corporate identity

Company profile

Not yet verified
Company type
Pharmaceutical manufacturer
DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000503 121 linked products · source seen 10 Aug 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet verified

MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx121product presentations
G55generic molecules
DF9dosage-form groups
TA10therapeutic areas
PKR121current price records
REG112registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage94%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMedisure Laboratories Pakistan Pvt LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 11 Aug 2026Anti-infectives64 · 53%CNS & mental health23 · 19%Gastrointestinal & hepatology11 · 9%Cardiovascular8 · 7%Hematology & thrombosis7 · 6%Endocrine & metabolic2 · 2%Pain & musculoskeletal2 · 2%Other therapeutic areas4 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMedisure Laboratories Pakistan Pvt LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 11 Aug 2026121presentationsTablet62 · 51%Injection27 · 22%Capsule10 · 8%Cream6 · 5%Infusion5 · 4%Suspension5 · 4%Other forms6 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent-Market Price Position

Shows whether safely comparable products are below, near or above the market median unit price.

Equivalent-Market Price PositionMedisure Laboratories Pakistan Pvt LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 11 Aug 2026112comparable productsBelow market median90 · 80%Near market median15 · 13%Above market median7 · 6%Company median price position-17.8%Lowest-price equivalents16Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMedisure Laboratories Pakistan Pvt LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medisure-laboratories-pakistan-pvt-ltdGenerated 11 Aug 2026Nabiqasim Industries (Pvt) Ltd.,40 shared73% overlapMediate Pharmaceutical Pvt Ltd38 shared69% overlapNeutro Pharma (Pvt.) Ltd.,37 shared67% overlapEpharm Laboratories35 shared64% overlapPharmasol (Pvt) Ltd.34 shared62% overlapCCL Pharmaceuticals (Pvt.) Ltd.34 shared62% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives64 products · 53%
CNS & mental health23 products · 19%
Gastrointestinal & hepatology11 products · 9%
Cardiovascular8 products · 7%
Hematology & thrombosis7 products · 6%
Endocrine & metabolic2 products · 2%
Pain & musculoskeletal2 products · 2%
Oncology & immunology2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins21 products · 17%
Antiepileptics13 products · 11%
Fluoroquinolone antibacterials9 products · 7%
Antipsychotics8 products · 7%
Macrolide antibacterials7 products · 6%
Antimalarials6 products · 5%
Antiemetics4 products · 3%
Antifungals4 products · 3%
Formulation footprint

Dosage forms

Tablet62 products
Injection27 products
Capsule10 products
Cream6 products
Infusion5 products
Suspension5 products
Solution3 products
Drops2 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 CefsureCeftriaxone 10presentations 1 g, 2 g, 250 mg, 500 mg · Injection #2 TamlevLevetiracetam 7presentations 100 mg/mL, 250 mg, 500 mg/5 mL, 750 mg · Solution, Tablet, Injection #3 AmesureCiprofloxacin 6presentations 0.3 %, 200 mg/100 mL, 250 mg, 500 mg · Tablet, Infusion #4 ClarocinClarithromycin 4presentations 125 mg/5 mL, 250 mg, 500 mg · Drops, Tablet, Infusion #5 QuopineQuetiapine 4presentations 100 mg, 200 mg, 25 mg, 300 mg · Tablet #6 SuresefCefotaxime 4presentations 1 g, 2 g, 250 mg, 500 mg · Injection
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median9080% of comparable products
Near market median15within ±5% of median
Above market median76% of comparable products
Lowest-price equivalents16ties included
Company median price position -17.8% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Ylenol 500 mgParacetamol · Tablet · 10 x 10's PKR 0.80/tablet-77.5% vs market median Penicillamine D-Penicillamine … 250 mgPenicillamine · Tablet · 10's PKR 23.22/tablet-64.2% vs market median Biofloxacin 400 mgMoxifloxacin · Tablet · 1 x 5's PKR 77.41/tablet-57.1% vs market median Tamlev 750 mgLevetiracetam · Tablet · 30's PKR 67.12/tablet-48.8% vs market median Lactusure 3.35 gLactulose · Syrup · 120ml PKR 1.41/mL-40.2% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,362 products · 118 generics 40shared generics Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 38shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 37shared generics Epharm Laboratories144 products · 67 generics 35shared generics Pharmasol (Pvt) Ltd.251 products · 101 generics 34shared generics CCL Pharmaceuticals (Pvt.) Ltd.243 products · 90 generics 34shared generics
Regulatory & price activity

Observed database signals

Registration numbers112
Price-history records130
Products with price history7
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date21 Oct 2025
Latest source observation10 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

63 results
Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Ceftazime Ceftazidime 500 mg Injection 1's 096856 PKR 203.58 PKR 203.58/vial/unit 16% below median
Ceftazime Ceftazidime 250 mg Injection 1's 096855 PKR 133.84 PKR 133.84/vial/unit 16% below median
Ceftazime Ceftazidime 1 g Injection 1's 096857 PKR 382.39 PKR 382.39/vial/unit 16% below median
Cefxin Cefuroxime 750 mg Injection 1's 092655 PKR 154.81 PKR 154.81/vial/unit 17% below median
Cefxin Cefuroxime 250 mg Injection 1's 092656 PKR 43.35 PKR 43.35/vial/unit 20% below median
Chlorosure Chloroquine 250 mg Tablet 50*10's 105566 PKR 614.32 PKR 1.23/tablet 21% below median
Clarocin Clarithromycin 500 mg IV infusion 1's 080301 PKR 123.85 PKR 123.85/vial/unit 27% below median
Clarocin Clarithromycin 125 mg/5 mL Oral drops 60ml 032033 PKR 309.62 PKR 5.16/mL 30% below median
Clarocin Clarithromycin 250 mg Tablet 1 x 10's 029236 PKR 464.43 PKR 46.44/tablet Near median
Clarocin Clarithromycin 500 mg Tablet 1 x 10's 031149 PKR 820.50 PKR 82.05/tablet Near median
Evaxosure Levofloxacin 250 mg Tablet 10's 044249 PKR 387.03 PKR 38.70/tablet 19% below median
Evaxosure Levofloxacin 500 mg Tablet 10's 044250 PKR 644.01 PKR 64.40/tablet 18% below median
Fungista Clotrimazole 1 % Cream 10gm 032809 PKR 77.41 PKR 7.74/g 27% above median
Herpex Aciclovir 5 % Cream 10gm 039473 PKR 263.18 PKR 26.32/g 24% below median
IsIs Doxycycline 100 mg Capsule 10 x 10's 029238 PKR 774.05 PKR 7.74/capsule Near median
IsIs Doxycycline 100 mg Tablet 10 x 10's 029237 PKR 774.05 PKR 7.74/tablet Near median
Mal-Anx Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 055597 PKR 495.39 PKR 30.96/tablet 20% below median
Mal-Anx Artemether 40 mg Tablet 8's 061446 PKR 408.70 PKR 51.09/tablet 18% below median
Mal-Anx Artemether 80 mg/mL Injection 6's * 1ml Ampoule 073482 PKR 928.86 — No comparator
Malanx DS Plus Artemether + Lumefantrine 80 mg + 480 mg Tablet 4's 070724 PKR 340.58 PKR 85.15/tablet 22% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.